As a positive drug treatments Silymarin 50 mg/kg, also well showed beneficial properties on TAA-induced liver fibrosis by controlling of SIRT1/AMPKα signaling pathways with statistical significances as compared with the control group (p < 0.01, Figure 5A–C). Here, SIRT1 is linked to Hepatic fibrosis.